98%
921
2 minutes
20
Small ruminant lentiviruses (SRLVs) are a heterogeneous group of viruses that infect goats and sheep worldwide, for which no cures or effective vaccines are available. Control measures have been based on early diagnosis and accurate management with limited success due to re-emergence of seropositivity and disease in controlled flocks. Association between the genetic variation in the ovine transmembrane 154 () gene and susceptibility to certain viral subtypes was previously demonstrated, representing a possible control strategy to reduce infection prevalence in sheep. Thus, the identification of the resistance spectrum of E35K SNP within genotypes toward SRLV subtypes becomes crucial. In this study, 10 skin fibroblastic cell lines, from animals encoding three genotypes of the (E35K) SNP, were infected with 8 SRLV viral strains and tested for the presence of retrotranscriptase (RT) activity and cytopathic effect. Additionally, SRLV entry into cells was evaluated using viral pseudotypes. Two out of the eight viral strains showed fewer syncytia, reduced cell fusion degree, and lower RT activity in the supernatant of homozygous KK cell lines, suggesting a resistant pattern in these cells. The entry assay revealed a statistically significant difference between the three cell lines in seven of the eight strains, suggesting an entry blockade as the primary restriction factor in KK cells. These findings support the potential use of the gene as a marker for the genetic selection of resistant animals to specific SRLV subtypes. Moreover, the approach was validated as a valuable tool for studying resistance patterns against different SRLV strains.IMPORTANCESmall ruminant lentiviruses are worldwide spread pathogens that impact animal health and result in severe economic losses. Considering the high genetic and antigenic variability of these viruses and the absence of an effective cure or vaccine, the genetic selection of resistant animals based on the gene represents an interesting opportunity to control the infection. Thus, this study aimed to investigate further the host-pathogen interaction considering the association between the animal genotype for the suggested protective mutation and the infecting virus genotype using an model. The study confirmed genetic variation as a helpful predictive factor for SRLV susceptibility by particular SRLV strains including the highly pathogenic B1 subtype, while susceptibility to some A and the B2 subtypes was not affected by the gene. Once more, it highlighted the importance of monitoring circulating viral variants for the effective control of SRLV infection through genetic selection programs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1128/jvi.00961-25 | DOI Listing |
Br J Haematol
September 2025
Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Refractory cytomegalovirus (CMV) infection is a severe complication following umbilical cord blood transplantation (UCBT). Antiviral agents, the standard first-line therapy, are limited by toxicity and resistance without robust T-cell immunity. We evaluated third-party donor (TPD)-derived CMV-specific T cells (CMVSTs) as a treatment option.
View Article and Find Full Text PDFJ Biomed Sci
September 2025
Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Background: PPM1D (protein phosphatase Mg⁺/Mn⁺ dependent 1D) is a Ser/Thr phosphatase that negatively regulates p53 and functions as an oncogenic driver. Its gene amplification and overexpression are frequently observed in various malignancies and disruption of PPM1D degradation has also been reported as a cause of cancer progression. However, the precise mechanisms regulating PPM1D stability remain to be elucidated.
View Article and Find Full Text PDFBr J Pharmacol
September 2025
Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Background And Purpose: Neuroinflammation is increasingly recognised to contribute to drug-resistant epilepsy. Activation of ATP-gated P2X7 receptors has emerged as an important upstream mechanism, and increased P2X7 receptor expression is present in the seizure focus in rodent models and patients. Pharmacological antagonists of P2X7 receptors attenuate seizures in rodents, but this has not been explored in human neural networks.
View Article and Find Full Text PDFOncogene
September 2025
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pancreatic cancer is a highly aggressive malignancy with a dismal prognosis, characterized by a complex tumor microenvironment that promotes immunosuppression and limits the efficacy of immune checkpoint blockade (ICB) therapy. Fibroblast activation protein (FAP) is overexpressed in the tumor stroma and represents a promising target for therapeutic intervention. Here, we developed a novel antibody-drug conjugate (ADC) targeting FAP, and investigated its anti-tumor activity and ability to enhance ICB efficacy in pancreatic cancer.
View Article and Find Full Text PDFOncogene
September 2025
Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Resistance to platinum-based drugs and PARP inhibitors (PARPi) is the leading cause of treatment failure in epithelial ovarian cancer (EOC). This study aimed to identify resistance mechanisms shared by both. Using bioinformatic analyses, EOC tissues, primary tumor cells and organoids, and chemoresistant cell lines, we identified lymphoid enhancer-binding factor 1 (LEF1) as a candidate, whose expression was increased in both platinum-resistant and PARPi-resistant tumors.
View Article and Find Full Text PDF